Pacira BioSciences
PCRX
PCRX
211 hedge funds and large institutions have $1.72B invested in Pacira BioSciences in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 71 increasing their positions, 61 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
9% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 46
3% less funds holding
Funds holding: 218 → 211 (-7)
8% less capital invested
Capital invested by funds: $1.86B → $1.72B (-$141M)
Holders
211
Holding in Top 10
6
Calls
$6.54M
Puts
$4.05M
Top Buyers
| 1 | +$131M | |
| 2 | +$45.7M | |
| 3 | +$28.8M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$20M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$19.6M |
Top Sellers
| 1 | -$122M | |
| 2 | -$32.2M | |
| 3 | -$31.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$31.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$19.3M |